Literature DB >> 29940576

Similarities in the Computed Tomography Appearance in α1-Antitrypsin Deficiency and Smoking-Related Chronic Obstructive Pulmonary Disease in a Smoking Collective.

Philip Konietzke1,2,3, Bertram Jobst1,2,3, Willi L Wagner1,2,3, Inga Jarosch4, Ralph Graber5, Klaus Kenn4, Hans-Ulrich Kauczor1,2,3, Mark O Wielpütz1,2,3.   

Abstract

BACKGROUND: Emphysematous destruction of lung parenchyma visible in computed tomography (CT) can be attributed to chronic obstructive pulmonary disease (COPD) or to α1-antitrypsin deficiency (AATD).
OBJECTIVES: We evaluated if visual semiquantitative phenotyping of CT data helps identifying individuals with AATD in a group of smokers with severe emphysema and airflow limitation.
METHOD: n = 14 patients with AATD and n = 15 with COPD and a minimum of 10 pack years underwent CT, clinical assessment, and full-body plethysmography. The extent and type of emphysema as well as large and small airway changes were rated semiquantitatively for each lobe using a standardized previously published scoring system. Lastly, a final diagnosis for each patient was proposed.
RESULTS: AATD had a significantly lower mean emphysema score than COPD, with 8.9 ± 3.4 versus 11.9 ± 3.2 (p < 0.001), respectively. Within both groups, there was significantly more emphysema in the lower lobes (p < 0.05-0.001). The COPD group showed an upper- and middle-lobe predominance of emphysema distribution when compared to the AATD group (p < 0.001). Centrilobular (CLE) and panlobular (PLE) emphysema patterns showed a uniform distribution within both groups, with a CLE predominance in the upper lung and a PLE predominance in the lower lung regions. AATD and COPD both showed significantly more airway changes in lower lobes compared to upper lobes (p = 0.05-0.001), without significant differences between both groups.
CONCLUSION: The typical emphysema distribution patterns seen on CT traditionally assigned to AATD and COPD were of little use in discriminating both entities. Also, airway changes could not contribute to a more precise differentiation. We conclude that a concise standardized phenotyping-driven approach to chest CT in emphysema is not sufficient to identify patients with AATD in a cohort of smokers with advanced emphysema.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Differentiation; Imaging; Smoker; α1-Antitrypsin deficiency

Mesh:

Year:  2018        PMID: 29940576     DOI: 10.1159/000489177

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  1 in total

1.  Quantitative CT detects progression in COPD patients with severe emphysema in a 3-month interval.

Authors:  Philip Konietzke; Mark O Wielpütz; Willi L Wagner; Felix Wuennemann; Hans-Ulrich Kauczor; Claus P Heussel; Monika Eichinger; Ralf Eberhardt; Daniela Gompelmann; Oliver Weinheimer
Journal:  Eur Radiol       Date:  2020-01-21       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.